All In Biotech

Drug Trial Radar · NCT02818660

Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests

Mass Spectrometry Based Cutoffs for Cortisol and 17-hydroxy-progesterone (17-OH-progesterone) After Stimulation Tests for Primary and Secondary Adrenal Insufficiency.

Last checked: Nov 19, 2026Latest source record: Mar 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

232

Actual

Start

May 21, 2016

Primary completion

Dec 21, 2017

Study completion Dec 21, 2017

Sponsor

Lead sponsor
Haukeland University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 30, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

There are two main stimulation tests used to decide if a patient has cortisol deficiency. It is the "synacthen test", were we stimulate the patient with intramuscular or intravenous synacthen ( ACTH) to see how much cortisol the adrenals are capable of producing, and it is the "Insulin hypoglycemia test" were we give the patient insulin to provoke a hypoglycemia, and look at the adrenal response to that stimulus. The cut off values for a normal response is based on old immunological assays no longer in use. Assays with a lot of interference and cross reactivity leading to measurement of higher values for cortisol than what we measure on the highly specific LCMS/MS ( Liquid chromatography mass spectrometry methode) that we are using for cortisol today. So, there is a need for new cut off values for a normal response to such tests. The purpose of this study is to produce such new cutoff values by performing the test in 120 healthy controls. We also want to perform the test in patient groups normally going trough this tests according to the same protocol as the control persons, to evaluate the new cutoffs in different patient groups.

Conditions

  • Adrenal Insufficiency

Interventions

  • SynachtenDrug

    To stimulate the adrenals to increase the cortisol Production as much as possible

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Define a cutoff level for serum cortisol after stimulation with synacthen or hypoglycemia in healthy control persons.Time frame: 2 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Haukeland University hopsital

    Bergen, Norway

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.